alexa Onkar S. Vaze | PTC Therapeutics Inc.
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Onkar S. Vaze

Onkar S. Vaze Onkar S. Vaze
Formulation Scientist
PTC Therapeutics Inc.,
New Jersey, USA
 
Biography

Dr.Vaze is a Formulation Scientist at PTC Therapeutics, Inc., New Jersey, USA. He attended Northeastern University, Boston, MA where in 2012 he received a PhD in Pharmaceutical Sciences with specialization in Pharmaceutics and Drug Delivery systems. Doctoral dissertation involved development of a lipid-based delivery system for a small molecule drug, using pharmaceutical nanocarriers to specifically target and inhibit cancer cell multiplication in vitro and in vivo and development of a lipid-based system for effective stabilization and enhanced delivery of small interfering RNAs (siRNA). Dr.Vaze has co-authored research papers and a book chapter in high impact scientific international peer reviewed journals. He has more than seven years of academic/industrial experience designing, planning, and conducting comprehensive research, analysis, and experimentation to drive the development of new drug formulations. He has experience in preformulation studies, preclinical formulations and formulation development of small and large molecules and has a strong understanding of US-FDA guidelines. He has also served as a reviewer for high impact peer reviewed scientific journals

Research Interest

• Preformulation, preclinical formulations and Formulation development (small and large molecules like small interfering RNAs)
• Nanocarriers (liposomes, micelles, nanoparticles) • Pharmaceutics and Drug Delivery
• SMEDDS and SEDDS
• Solid Dosage form: Tablets, capsules, Drug excipient compatibility, Design of experiments, Quality by design
• Pharmaceutical Technologies: Amorphous dispersions, Hot melt extrusion

Publications

Pharmaceutical Nanocarriers (Liposomes and Micelles) in Cancer Therapy
Onkar S. Vaze
Editorial: J Nanomed Nanotechnol 2016, 7: e138
DOI: 10.4172/2157-7439.1000e138
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords